Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich’s Ataxia: A New Synthetic Route
Friedreich’s ataxia (FRDA) is caused by transcriptional repression of the nuclear FXN gene encoding the essential mitochondrial protein frataxin. Based on the hypothesis that the acetylation state of the histone proteins is responsible for gene silencing in FRDA, previous work in our lab identified...
Main Authors: | Joel M. Gottesfeld, James R. Rusche, Elisabetta Soragni, Vincent Jacques, Chunping Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/4/12/1578/ |
Similar Items
-
Mechanism of action of 2-aminobenzamide HDAC inhibitors in reversing gene silencing in Friedreich’s ataxia
by: Elisabetta eSoragni, et al.
Published: (2015-03-01) -
Anesthetic Management on a Patient with Friedreichs Ataxia
by: Ulku Ozgul, et al.
Published: (2013-12-01) -
Respiratory Function in Friedreich’s Ataxia
by: Elena Vinante, et al.
Published: (2022-08-01) -
Diagnostic Delay and Clinical Features in Friedreich’s Ataxia
by: Mehmet Fatih Yetkin, et al.
Published: (2022-06-01) -
Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model
by: Chiranjeevi Sandi, et al.
Published: (2011-06-01)